Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) - Share price


Stock Report

Alnylam Pharmaceuticals Inc ALNY

Balance Sheet Items (in % Terms)
20152016201720182019
Cash & Short Term Investments77.93%49.64%84.75%68.84%64.14%
Accounts receivable0.60%1.85%1.70%1.19%1.80%
Inventory---1.53%2.35%
Other Current Assets1.19%1.72%2.01%4.68%3.35%
Total current assets79.72%53.20%88.47%76.24%71.64%
Net PP&E2.01%9.07%9.12%20.36%26.99%
Intangibles-----
Other Long-Term Assets18.27%37.72%2.41%3.39%1.37%
Total Assets100.00%100.00%100.00%100.00%100.00%
Accounts Payable1.21%4.31%1.42%3.79%2.08%
Current Debt-----
Taxes Payable-----
Accrued liabilities1.27%2.25%1.92%4.79%5.38%
Other current liabilities2.00%3.86%3.89%2.82%7.26%
Total current liabilities4.48%10.43%7.23%11.40%14.72%
Long Term Debt-11.88%1.50%1.91%-
Other long-term liabilities-4.82%2.71%4.02%-
Total Liabilities8.78%27.13%11.45%17.33%39.93%
Total stockholders' equity91.22%72.87%88.55%82.67%60.07%
Total Liabilities and Equity100.00%100.00%100.00%100.00%100.00%
Liquidity/Financial Health
20152016201720182019
Current Ratio17.805.1012.236.694.87
Quick Ratio17.534.9411.966.144.48
Financial Leverage1.101.371.131.211.66
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.